Global Benign Prostatic Hyperplasia Devices Market Insights, Forecast to 2025

1 Study Coverage

• 1.1 Benign Prostatic Hyperplasia Devices Product Introduction
• 1.2 Key Market Segments in This Study
• 1.3 Key Manufacturers Covered: Ranking of Global Top Benign Prostatic Hyperplasia Devices Manufacturers by Revenue in 2019
• 1.4 Market by Type
  • 1.4.1 Global Benign Prostatic Hyperplasia Devices Market Size Growth Rate by Type
  • 1.4.2 Transurethral Resection of the Prostate (TURP)
  • 1.4.3 Transurethral Microwave Therapy (TUMT)
  • 1.4.4 Transurethral Needle Ablation of the Prostate (TUNA)
  • 1.4.5 Laser Surgery
  • 1.4.6 Prostatic Stenting
  • 1.4.7 Others
• 1.5 Market by Application
  • 1.5.1 Global Benign Prostatic Hyperplasia Devices Market Size Growth Rate by Application
  • 1.5.2 Hospitals and Clinics
  • 1.5.3 Ambulatory Surgical Centers(ASC)
  • 1.5.4 Home
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Benign Prostatic Hyperplasia Devices Market Size, Estimates and Forecasts
  • 2.1.1 Global Benign Prostatic Hyperplasia Devices Revenue Estimates and Forecasts 2015-2026
  • 2.1.2 Global Benign Prostatic Hyperplasia Devices Production Capacity Estimates and Forecasts 2015-2026
  • 2.1.3 Global Benign Prostatic Hyperplasia Devices Production Estimates and Forecasts 2015-2026
• 2.2 Global Benign Prostatic Hyperplasia Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
• 2.3 Analysis of Competitive Landscape
  • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 2.3.2 Global Benign Prostatic Hyperplasia Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.3.3 Global Benign Prostatic Hyperplasia Devices Manufacturers Geographical Distribution
• 2.4 Key Trends for Benign Prostatic Hyperplasia Devices Markets & Products
• 2.5 Primary Interviews with Key Benign Prostatic Hyperplasia Devices Players (Opinion Leaders)

3 Market Size by Manufacturers

• 3.1 Global Top Benign Prostatic Hyperplasia Devices Manufacturers by Production Capacity
  • 3.1.1 Global Top Benign Prostatic Hyperplasia Devices Manufacturers by Production Capacity (2015-2020)
  • 3.1.2 Global Top Benign Prostatic Hyperplasia Devices Manufacturers by Production (2015-2020)
  • 3.1.3 Global Top Benign Prostatic Hyperplasia Devices Manufacturers Market Share by Production
• 3.2 Global Top Benign Prostatic Hyperplasia Devices Manufacturers by Revenue
  • 3.2.1 Global Top Benign Prostatic Hyperplasia Devices Manufacturers by Revenue (2015-2020)
  • 3.2.2 Global Top Benign Prostatic Hyperplasia Devices Manufacturers Market Share by Revenue (2015-2020)
  • 3.2.3 Global Top 10 and Top 5 Companies by Benign Prostatic Hyperplasia Devices Revenue in 2019
• 3.3 Global Benign Prostatic Hyperplasia Devices Price by Manufacturers
• 3.4 Mergers & Acquisitions, Expansion Plans

4 Benign Prostatic Hyperplasia Devices Production by Regions

• 4.1 Global Benign Prostatic Hyperplasia Devices Historic Market Facts & Figures by Regions
  • 4.1.1 Global Top Benign Prostatic Hyperplasia Devices Regions by Production (2015-2020)
  • 4.1.2 Global Top Benign Prostatic Hyperplasia Devices Regions by Revenue (2015-2020)
• 4.2 North America
  • 4.2.1 North America Benign Prostatic Hyperplasia Devices Production (2015-2020)
  • 4.2.2 North America Benign Prostatic Hyperplasia Devices Revenue (2015-2020)
  • 4.2.3 Key Players in North America
  • 4.2.4 North America Benign Prostatic Hyperplasia Devices Import & Export (2015-2020)
• 4.3 Europe
  • 4.3.1 Europe Benign Prostatic Hyperplasia Devices Production (2015-2020)
  • 4.3.2 Europe Benign Prostatic Hyperplasia Devices Revenue (2015-2020)
  • 4.3.3 Key Players in Europe
  • 4.3.4 Europe Benign Prostatic Hyperplasia Devices Import & Export (2015-2020)
• 4.4 China
  • 4.4.1 China Benign Prostatic Hyperplasia Devices Production (2015-2020)
  • 4.4.2 China Benign Prostatic Hyperplasia Devices Revenue (2015-2020)
  • 4.4.3 Key Players in China
  • 4.4.4 China Benign Prostatic Hyperplasia Devices Import & Export (2015-2020)
• 4.5 Japan
  • 4.5.1 Japan Benign Prostatic Hyperplasia Devices Production (2015-2020)
  • 4.5.2 Japan Benign Prostatic Hyperplasia Devices Revenue (2015-2020)
  • 4.5.3 Key Players in Japan
  • 4.5.4 Japan Benign Prostatic Hyperplasia Devices Import & Export (2015-2020)

5 Benign Prostatic Hyperplasia Devices Consumption by Region

• 5.1 Global Top Benign Prostatic Hyperplasia Devices Regions by Consumption
  • 5.1.1 Global Top Benign Prostatic Hyperplasia Devices Regions by Consumption (2015-2020)
  • 5.1.2 Global Top Benign Prostatic Hyperplasia Devices Regions Market Share by Consumption (2015-2020)
• 5.2 North America
  • 5.2.1 North America Benign Prostatic Hyperplasia Devices Consumption by Application
  • 5.2.2 North America Benign Prostatic Hyperplasia Devices Consumption by Countries
  • 5.2.3 U.S.
  • 5.2.4 Canada
• 5.3 Europe
  • 5.3.1 Europe Benign Prostatic Hyperplasia Devices Consumption by Application
  • 5.3.2 Europe Benign Prostatic Hyperplasia Devices Consumption by Countries
  • 5.3.3 Germany
  • 5.3.4 France
  • 5.3.5 U.K.
  • 5.3.6 Italy
  • 5.3.7 Russia
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Benign Prostatic Hyperplasia Devices Consumption by Application
  • 5.4.2 Asia Pacific Benign Prostatic Hyperplasia Devices Consumption by Regions
  • 5.4.3 China
  • 5.4.4 Japan
  • 5.4.5 South Korea
  • 5.4.6 India
  • 5.4.7 Australia
  • 5.4.8 Taiwan
  • 5.4.9 Indonesia
  • 5.4.10 Thailand
  • 5.4.11 Malaysia
  • 5.4.12 Philippines
  • 5.4.13 Vietnam
• 5.5 Central & South America
  • 5.5.1 Central & South America Benign Prostatic Hyperplasia Devices Consumption by Application
  • 5.5.2 Central & South America Benign Prostatic Hyperplasia Devices Consumption by Country
  • 5.5.3 Mexico
  • 5.5.3 Brazil
  • 5.5.3 Argentina
• 5.6 Middle East and Africa
  • 5.6.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Consumption by Application
  • 5.6.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Consumption by Countries
  • 5.6.3 Turkey
  • 5.6.4 Saudi Arabia
  • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

• 6.1 Global Benign Prostatic Hyperplasia Devices Market Size by Type (2015-2020)
  • 6.1.1 Global Benign Prostatic Hyperplasia Devices Production by Type (2015-2020)
  • 6.1.2 Global Benign Prostatic Hyperplasia Devices Revenue by Type (2015-2020)
  • 6.1.3 Benign Prostatic Hyperplasia Devices Price by Type (2015-2020)
• 6.2 Global Benign Prostatic Hyperplasia Devices Market Forecast by Type (2021-2026)
  • 6.2.1 Global Benign Prostatic Hyperplasia Devices Production Forecast by Type (2021-2026)
  • 6.2.2 Global Benign Prostatic Hyperplasia Devices Revenue Forecast by Type (2021-2026)
  • 6.2.3 Global Benign Prostatic Hyperplasia Devices Price Forecast by Type (2021-2026)
• 6.3 Global Benign Prostatic Hyperplasia Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

• 7.2.1 Global Benign Prostatic Hyperplasia Devices Consumption Historic Breakdown by Application (2015-2020)
• 7.2.2 Global Benign Prostatic Hyperplasia Devices Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

• 8.1 Lumenis
  • 8.1.1 Lumenis Corporation Information
  • 8.1.2 Lumenis Overview
  • 8.1.3 Lumenis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.1.4 Lumenis Product Description
  • 8.1.5 Lumenis Related Developments
• 8.2 Olympus corporation
  • 8.2.1 Olympus corporation Corporation Information
  • 8.2.2 Olympus corporation Overview
  • 8.2.3 Olympus corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.2.4 Olympus corporation Product Description
  • 8.2.5 Olympus corporation Related Developments
• 8.3 Urologix
  • 8.3.1 Urologix Corporation Information
  • 8.3.2 Urologix Overview
  • 8.3.3 Urologix Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.3.4 Urologix Product Description
  • 8.3.5 Urologix Related Developments
• 8.4 Boston Scientific corporation
  • 8.4.1 Boston Scientific corporation Corporation Information
  • 8.4.2 Boston Scientific corporation Overview
  • 8.4.3 Boston Scientific corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.4.4 Boston Scientific corporation Product Description
  • 8.4.5 Boston Scientific corporation Related Developments
• 8.5 Lisa Laser
  • 8.5.1 Lisa Laser Corporation Information
  • 8.5.2 Lisa Laser Overview
  • 8.5.3 Lisa Laser Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.5.4 Lisa Laser Product Description
  • 8.5.5 Lisa Laser Related Developments
• 8.6 Medifocus
  • 8.6.1 Medifocus Corporation Information
  • 8.6.2 Medifocus Overview
  • 8.6.3 Medifocus Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.6.4 Medifocus Product Description
  • 8.6.5 Medifocus Related Developments
• 8.7 Neotrac
  • 8.7.1 Neotrac Corporation Information
  • 8.7.2 Neotrac Overview
  • 8.7.3 Neotrac Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.7.4 Neotrac Product Description
  • 8.7.5 Neotrac Related Developments
• 8.8 ProArc Medical LTD
  • 8.8.1 ProArc Medical LTD Corporation Information
  • 8.8.2 ProArc Medical LTD Overview
  • 8.8.3 ProArc Medical LTD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.8.4 ProArc Medical LTD Product Description
  • 8.8.5 ProArc Medical LTD Related Developments
• 8.9 Urotech GMBH
  • 8.9.1 Urotech GMBH Corporation Information
  • 8.9.2 Urotech GMBH Overview
  • 8.9.3 Urotech GMBH Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.9.4 Urotech GMBH Product Description
  • 8.9.5 Urotech GMBH Related Developments

9 Benign Prostatic Hyperplasia Devices Production Forecast by Regions

• 9.1 Global Top Benign Prostatic Hyperplasia Devices Regions Forecast by Revenue (2021-2026)
• 9.2 Global Top Benign Prostatic Hyperplasia Devices Regions Forecast by Production (2021-2026)
• 9.3 Key Benign Prostatic Hyperplasia Devices Production Regions Forecast
  • 9.3.1 North America
  • 9.3.2 Europe
  • 9.3.3 China
  • 9.3.4 Japan

10 Benign Prostatic Hyperplasia Devices Consumption Forecast by Region

• 10.1 Global Benign Prostatic Hyperplasia Devices Consumption Forecast by Region (2021-2026)
• 10.2 North America Benign Prostatic Hyperplasia Devices Consumption Forecast by Region (2021-2026)
• 10.3 Europe Benign Prostatic Hyperplasia Devices Consumption Forecast by Region (2021-2026)
• 10.4 Asia Pacific Benign Prostatic Hyperplasia Devices Consumption Forecast by Region (2021-2026)
• 10.5 Latin America Benign Prostatic Hyperplasia Devices Consumption Forecast by Region (2021-2026)
• 10.6 Middle East and Africa Benign Prostatic Hyperplasia Devices Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Benign Prostatic Hyperplasia Devices Sales Channels
  • 11.2.2 Benign Prostatic Hyperplasia Devices Distributors
• 11.3 Benign Prostatic Hyperplasia Devices Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

• 12.1 Benign Prostatic Hyperplasia Devices Industry
• 12.2 Market Trends
• 12.3 Market Opportunities and Drivers
• 12.4 Market Challenges
• 12.5 Benign Prostatic Hyperplasia Devices Market Risks/Restraints
• 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Benign Prostatic Hyperplasia Devices Study

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details